— Know what they know.
Not Investment Advice

603882.SS SHH

Guangzhou Kingmed Diagnostics Group Co., Ltd.
1W: +0.0% 1M: +6.1% 3M: +24.1% YTD: -9.5% 1Y: -3.8% 3Y: -58.6% 5Y: -77.8%
¥29.06 ($4.33)
+0.81 (+2.87%)
 
SHH · Healthcare · Medical - Diagnostics & Research · Tech Score Strong Buy · Power 68 · ¥13.5B mcap · 298M float · 2.94% daily turnover
Smart Money Score
Watch 25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap¥13.5B ($2.0B)
52W Range21.5-40.68
Volume12,054,017
Avg Volume8,755,376
Beta0.37
Dividend¥0.88
Analyst Ratings
No analyst coverage
Company Info
CEOYaoming Liang
Employees9,529
SectorHealthcare
IndustryMedical - Diagnostics & Research
IPO Date2017-09-08
No. 10, Helix 3rd Road
Guangzhou, GD 510000
CN
86 20 2228 3222
About Guangzhou Kingmed Diagnostics Group Co., Ltd.

Guangzhou Kingmed Diagnostics Group Co., Ltd. operates as a prominent independent medical laboratory provider. Its extensive service portfolio encompasses a wide array of offerings, such as medical diagnostic information, clinical trial assistance, and comprehensive laboratory services. The company also specializes in food and hygiene testing, health management solutions, and medical cold chain logistics. Additionally, Kingmed engages in scientific research, develops in vitro diagnostics, and utilizes advanced capabilities in healthcare big data, artificial intelligence, and forensic testing. Operating a network of 37 state-of-the-art testing facilities, the company maintains a significant presence across both mainland China and Hong Kong. Established in 2003, its corporate headquarters are situated in Guangzhou, China.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms